APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucellosis Vaccines

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Selected research

Market Analysis & Forecast

Global Brucellosis Vaccines Market Analysis and Forecast 2026-2032

21 December 2025203 pages

Choose your research edition.

Industry ResearchBrucellosis Vaccines Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucellosis Vaccines Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Brucellosis Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucellosis Vaccines Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucellosis Vaccines Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

Brucellosis vaccine is a vaccine for cattle, sheep and goats used against brucellosis. Currently, there is no vaccine available for humans.

Global Brucellosis Vaccines main players are Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, etc. Global top four manufacturers hold a share above 35%. China is the largest market, with a share about 30%.

This report presents an overview of global market for Brucellosis Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Brucellosis Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Brucellosis Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Brucellosis Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Brucellosis Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Brucellosis Vaccines sales, projected growth trends, production technology, application and end-user industry.

Brucellosis Vaccines Segment by Company

Jinyu

Colorado Serum

Boehringer Ingelheim

Biogenesis-Bago

Vetal Company

CZ Veterinaria

SYVA Laboratorios

Indian Immunologicals

Qilu

Tecnovax

Hester Biosciences

Zoetis

Onderstepoort Biological

Instituto Rosenbusch

Ceva Sante Animale

Calier & Biologicos Laverlam

Biovet

Brucellosis Vaccines Segment by Type

S19 Vaccine

RB51 Vaccine Strain

Brucellosis Vaccines Segment by Application

Cattle

Sheep

Others

Brucellosis Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucellosis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucellosis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucellosis Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Brucellosis Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Brucellosis Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Brucellosis Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Brucellosis Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. S19 Vaccine Major Manufacturers Table 3. RB51 Vaccine Strain Major Manufacturers Table 4. Global Brucellosis Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cattle Major Manufacturers Table 6. Sheep Major Manufacturers Table 7. Others Major Manufacturers Table 8. Brucellosis Vaccines Industry Trends Table 9. Brucellosis Vaccines Industry Drivers Table 10. Brucellosis Vaccines Industry Opportunities and Challenges Table 11. Brucellosis Vaccines Industry Restraints Table 12. Global Brucellosis Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Brucellosis Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Brucellosis Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Brucellosis Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Brucellosis Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Brucellosis Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 18. Global Brucellosis Vaccines Sales by Region (2021-2026) & (M Doses) Table 19. Global Brucellosis Vaccines Sales by Region (2027-2032) & (M Doses) Table 20. Global Brucellosis Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Brucellosis Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Brucellosis Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Brucellosis Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Brucellosis Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Brucellosis Vaccines Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 27. Global Brucellosis Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Brucellosis Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Brucellosis Vaccines Manufacturers, Product Type & Application Table 30. Global Brucellosis Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Brucellosis Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Brucellosis Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Brucellosis Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Brucellosis Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Brucellosis Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Brucellosis Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Brucellosis Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 39. Global Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 40. Global Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 41. Global Brucellosis Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Brucellosis Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Brucellosis Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 44. Global Brucellosis Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 45. Global Brucellosis Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Brucellosis Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Brucellosis Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Brucellosis Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Brucellosis Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Brucellosis Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 51. Global Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 53. Global Brucellosis Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Brucellosis Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Brucellosis Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Brucellosis Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 57. Jinyu Company Information Table 58. Jinyu Business Overview Table 59. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 60. Jinyu Brucellosis Vaccines Product Portfolio Table 61. Jinyu Recent Development Table 62. Colorado Serum Company Information Table 63. Colorado Serum Business Overview Table 64. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 65. Colorado Serum Brucellosis Vaccines Product Portfolio Table 66. Colorado Serum Recent Development Table 67. Boehringer Ingelheim Company Information Table 68. Boehringer Ingelheim Business Overview Table 69. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 70. Boehringer Ingelheim Brucellosis Vaccines Product Portfolio Table 71. Boehringer Ingelheim Recent Development Table 72. Biogenesis-Bago Company Information Table 73. Biogenesis-Bago Business Overview Table 74. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 75. Biogenesis-Bago Brucellosis Vaccines Product Portfolio Table 76. Biogenesis-Bago Recent Development Table 77. Vetal Company Company Information Table 78. Vetal Company Business Overview Table 79. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 80. Vetal Company Brucellosis Vaccines Product Portfolio Table 81. Vetal Company Recent Development Table 82. CZ Veterinaria Company Information Table 83. CZ Veterinaria Business Overview Table 84. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 85. CZ Veterinaria Brucellosis Vaccines Product Portfolio Table 86. CZ Veterinaria Recent Development Table 87. SYVA Laboratorios Company Information Table 88. SYVA Laboratorios Business Overview Table 89. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 90. SYVA Laboratorios Brucellosis Vaccines Product Portfolio Table 91. SYVA Laboratorios Recent Development Table 92. Indian Immunologicals Company Information Table 93. Indian Immunologicals Business Overview Table 94. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 95. Indian Immunologicals Brucellosis Vaccines Product Portfolio Table 96. Indian Immunologicals Recent Development Table 97. Qilu Company Information Table 98. Qilu Business Overview Table 99. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 100. Qilu Brucellosis Vaccines Product Portfolio Table 101. Qilu Recent Development Table 102. Tecnovax Company Information Table 103. Tecnovax Business Overview Table 104. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 105. Tecnovax Brucellosis Vaccines Product Portfolio Table 106. Tecnovax Recent Development Table 107. Hester Biosciences Company Information Table 108. Hester Biosciences Business Overview Table 109. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 110. Hester Biosciences Brucellosis Vaccines Product Portfolio Table 111. Hester Biosciences Recent Development Table 112. Zoetis Company Information Table 113. Zoetis Business Overview Table 114. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 115. Zoetis Brucellosis Vaccines Product Portfolio Table 116. Zoetis Recent Development Table 117. Onderstepoort Biological Company Information Table 118. Onderstepoort Biological Business Overview Table 119. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 120. Onderstepoort Biological Brucellosis Vaccines Product Portfolio Table 121. Onderstepoort Biological Recent Development Table 122. Instituto Rosenbusch Company Information Table 123. Instituto Rosenbusch Business Overview Table 124. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 125. Instituto Rosenbusch Brucellosis Vaccines Product Portfolio Table 126. Instituto Rosenbusch Recent Development Table 127. Ceva Sante Animale Company Information Table 128. Ceva Sante Animale Business Overview Table 129. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 130. Ceva Sante Animale Brucellosis Vaccines Product Portfolio Table 131. Ceva Sante Animale Recent Development Table 132. Calier & Biologicos Laverlam Company Information Table 133. Calier & Biologicos Laverlam Business Overview Table 134. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 135. Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio Table 136. Calier & Biologicos Laverlam Recent Development Table 137. Biovet Company Information Table 138. Biovet Business Overview Table 139. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 140. Biovet Brucellosis Vaccines Product Portfolio Table 141. Biovet Recent Development Table 142. North America Brucellosis Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Brucellosis Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 145. North America Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 146. North America Brucellosis Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 147. North America Brucellosis Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 148. North America Brucellosis Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Brucellosis Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 151. North America Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 152. North America Brucellosis Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 153. North America Brucellosis Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 154. North America Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Brucellosis Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Brucellosis Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 158. North America Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 159. North America Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 160. North America Brucellosis Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 161. North America Brucellosis Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 162. United States Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 163. Canada Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 164. Mexico Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 165. Europe Brucellosis Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 166. Europe Brucellosis Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 167. Europe Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 168. Europe Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 169. Europe Brucellosis Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 170. Europe Brucellosis Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 171. Europe Brucellosis Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 172. Europe Brucellosis Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 173. Europe Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 174. Europe Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 175. Europe Brucellosis Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 176. Europe Brucellosis Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 177. Europe Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Europe Brucellosis Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Europe Brucellosis Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Europe Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 181. Europe Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 182. Europe Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 183. Europe Brucellosis Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 184. Europe Brucellosis Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 185. Germany Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 186. France Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 187. U.K. Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 188. Italy Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 189. Russia Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 190. Spain Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 191. Netherlands Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 192. Switzerland Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 193. Sweden Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 194. Poland Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 195. China Brucellosis Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 196. China Brucellosis Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 197. China Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 198. China Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 199. China Brucellosis Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 200. China Brucellosis Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 201. China Brucellosis Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 202. China Brucellosis Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 203. China Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 204. China Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 205. China Brucellosis Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 206. China Brucellosis Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 207. Asia Brucellosis Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 208. Asia Brucellosis Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 209. Asia Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 210. Asia Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 211. Asia Brucellosis Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 212. Asia Brucellosis Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 213. Asia Brucellosis Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 214. Asia Brucellosis Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 215. Asia Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 216. Asia Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 217. Asia Brucellosis Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 218. Asia Brucellosis Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 219. Asia Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. Asia Brucellosis Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. Asia Brucellosis Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. Asia Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 223. Asia Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 224. Asia Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 225. Asia Brucellosis Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 226. Asia Brucellosis Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 227. Japan Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 228. South Korea Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 229. India Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 230. Australia Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 231. Taiwan Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 232. Southeast Asia Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 233. SAMEA Brucellosis Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 234. SAMEA Brucellosis Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 235. SAMEA Brucellosis Vaccines Sales by Type (2021-2026) & (M Doses) Table 236. SAMEA Brucellosis Vaccines Sales by Type (2027-2032) & (M Doses) Table 237. SAMEA Brucellosis Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 238. SAMEA Brucellosis Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 239. SAMEA Brucellosis Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 240. SAMEA Brucellosis Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 241. SAMEA Brucellosis Vaccines Sales by Application (2021-2026) & (M Doses) Table 242. SAMEA Brucellosis Vaccines Sales by Application (2027-2032) & (M Doses) Table 243. SAMEA Brucellosis Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 244. SAMEA Brucellosis Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 245. SAMEA Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 246. SAMEA Brucellosis Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 247. SAMEA Brucellosis Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 248. SAMEA Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 249. SAMEA Brucellosis Vaccines Sales by Country (2021-2026) & (M Doses) Table 250. SAMEA Brucellosis Vaccines Sales by Country (2027-2032) & (M Doses) Table 251. SAMEA Brucellosis Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 252. SAMEA Brucellosis Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 253. Brazil Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 254. Argentina Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 255. Chile Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 256. Colombia Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 257. Peru Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 258. Saudi Arabia Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 259. Israel Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 260. UAE Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 261. Turkey Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 262. Iran Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 263. Egypt Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Brucellosis Vaccines Distributors List Table 267. Brucellosis Vaccines Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Brucellosis Vaccines Image Figure 2. Global Brucellosis Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucellosis Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. S19 Vaccine Image Figure 5. RB51 Vaccine Strain Image Figure 6. Global Brucellosis Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Brucellosis Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cattle Image Figure 9. Sheep Image Figure 10. Others Image Figure 11. Global Brucellosis Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Brucellosis Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Brucellosis Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Brucellosis Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Brucellosis Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Brucellosis Vaccines Sales (2021-2032) & (M Doses) Figure 17. Global Brucellosis Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 18. Global Brucellosis Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Brucellosis Vaccines Sales YoY (2021-2032) & (M Doses) Figure 20. Europe Brucellosis Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. China Brucellosis Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. Asia (Excluding China) Brucellosis Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. South America, Middle East and Africa Brucellosis Vaccines Sales YoY (2021-2032) & (M Doses) Figure 24. Global Brucellosis Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Brucellosis Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Brucellosis Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Brucellosis Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Brucellosis Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Brucellosis Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 31. Global Brucellosis Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Brucellosis Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Brucellosis Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Brucellosis Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Brucellosis Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Brucellosis Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 37. Global Brucellosis Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Brucellosis Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Brucellosis Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Brucellosis Vaccines Sales Share by Type (2021-2032) Figure 41. North America Brucellosis Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Brucellosis Vaccines Sales Share by Application (2021-2032) Figure 43. North America Brucellosis Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Brucellosis Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Brucellosis Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Brucellosis Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Brucellosis Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Brucellosis Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Brucellosis Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Brucellosis Vaccines Sales Share by Country (2021-2032) Figure 51. China Brucellosis Vaccines Revenue Share by Type (2021-2032) Figure 52. China Brucellosis Vaccines Sales Share by Type (2021-2032) Figure 53. China Brucellosis Vaccines Revenue Share by Application (2021-2032) Figure 54. China Brucellosis Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Brucellosis Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Brucellosis Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Brucellosis Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Brucellosis Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Brucellosis Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Brucellosis Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Brucellosis Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Brucellosis Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Brucellosis Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Brucellosis Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Brucellosis Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Brucellosis Vaccines Sales Share by Country (2021-2032) Figure 67. Brucellosis Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Brucellosis Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • S19 Vaccine
  • RB51 Vaccine Strain
Applications
  • Cattle
  • Sheep
  • Others
Companies covered
  • Jinyu
  • Colorado Serum
  • Boehringer Ingelheim
  • Biogenesis-Bago
  • Vetal Company
  • CZ Veterinaria
  • SYVA Laboratorios
  • Indian Immunologicals
  • Qilu
  • Tecnovax
  • Hester Biosciences
  • Zoetis
  • Onderstepoort Biological
  • Instituto Rosenbusch
  • Ceva Sante Animale
  • Calier & Biologicos Laverlam
  • Biovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Brucellosis Vaccines Market by Type
  3. 1.2.1 Global Brucellosis Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 S19 Vaccine
  5. 1.2.3 RB51 Vaccine Strain
  6. 1.3 Brucellosis Vaccines Market by Application
  7. 1.3.1 Global Brucellosis Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cattle
  9. 1.3.3 Sheep
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Brucellosis Vaccines Market Dynamics
  1. 2.1 Brucellosis Vaccines Industry Trends
  2. 2.2 Brucellosis Vaccines Industry Drivers
  3. 2.3 Brucellosis Vaccines Industry Opportunities and Challenges
  4. 2.4 Brucellosis Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Brucellosis Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Brucellosis Vaccines Revenue by Region
  3. 3.2.1 Global Brucellosis Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Brucellosis Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Brucellosis Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Brucellosis Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Brucellosis Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Brucellosis Vaccines Sales by Region
  9. 3.4.1 Global Brucellosis Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Brucellosis Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Brucellosis Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Brucellosis Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Brucellosis Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Brucellosis Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Brucellosis Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Brucellosis Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Brucellosis Vaccines Sales by Manufacturers
  6. 4.2.1 Global Brucellosis Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Brucellosis Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Brucellosis Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Brucellosis Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Brucellosis Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Brucellosis Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Brucellosis Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Brucellosis Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Brucellosis Vaccines Tier 1, Tier 2, and Tier 3
5 Brucellosis Vaccines Market by Type
  1. 5.1 Global Brucellosis Vaccines Revenue by Type
  2. 5.1.1 Global Brucellosis Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Brucellosis Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Brucellosis Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Brucellosis Vaccines Sales by Type
  6. 5.2.1 Global Brucellosis Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Brucellosis Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Brucellosis Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Brucellosis Vaccines Price by Type
6 Brucellosis Vaccines Market by Application
  1. 6.1 Global Brucellosis Vaccines Revenue by Application
  2. 6.1.1 Global Brucellosis Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Brucellosis Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Brucellosis Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Brucellosis Vaccines Sales by Application
  6. 6.2.1 Global Brucellosis Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Brucellosis Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Brucellosis Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Brucellosis Vaccines Price by Application
7 Company Profiles
  1. 7.1 Jinyu
  2. 7.1.1 Jinyu Company Information
  3. 7.1.2 Jinyu Business Overview
  4. 7.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jinyu Brucellosis Vaccines Product Portfolio
  6. 7.1.5 Jinyu Recent Developments
  7. 7.2 Colorado Serum
  8. 7.2.1 Colorado Serum Company Information
  9. 7.2.2 Colorado Serum Business Overview
  10. 7.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Colorado Serum Brucellosis Vaccines Product Portfolio
  12. 7.2.5 Colorado Serum Recent Developments
  13. 7.3 Boehringer Ingelheim
  14. 7.3.1 Boehringer Ingelheim Company Information
  15. 7.3.2 Boehringer Ingelheim Business Overview
  16. 7.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Boehringer Ingelheim Brucellosis Vaccines Product Portfolio
  18. 7.3.5 Boehringer Ingelheim Recent Developments
  19. 7.4 Biogenesis-Bago
  20. 7.4.1 Biogenesis-Bago Company Information
  21. 7.4.2 Biogenesis-Bago Business Overview
  22. 7.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biogenesis-Bago Brucellosis Vaccines Product Portfolio
  24. 7.4.5 Biogenesis-Bago Recent Developments
  25. 7.5 Vetal Company
  26. 7.5.1 Vetal Company Company Information
  27. 7.5.2 Vetal Company Business Overview
  28. 7.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Vetal Company Brucellosis Vaccines Product Portfolio
  30. 7.5.5 Vetal Company Recent Developments
  31. 7.6 CZ Veterinaria
  32. 7.6.1 CZ Veterinaria Company Information
  33. 7.6.2 CZ Veterinaria Business Overview
  34. 7.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 CZ Veterinaria Brucellosis Vaccines Product Portfolio
  36. 7.6.5 CZ Veterinaria Recent Developments
  37. 7.7 SYVA Laboratorios
  38. 7.7.1 SYVA Laboratorios Company Information
  39. 7.7.2 SYVA Laboratorios Business Overview
  40. 7.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SYVA Laboratorios Brucellosis Vaccines Product Portfolio
  42. 7.7.5 SYVA Laboratorios Recent Developments
  43. 7.8 Indian Immunologicals
  44. 7.8.1 Indian Immunologicals Company Information
  45. 7.8.2 Indian Immunologicals Business Overview
  46. 7.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Indian Immunologicals Brucellosis Vaccines Product Portfolio
  48. 7.8.5 Indian Immunologicals Recent Developments
  49. 7.9 Qilu
  50. 7.9.1 Qilu Company Information
  51. 7.9.2 Qilu Business Overview
  52. 7.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Qilu Brucellosis Vaccines Product Portfolio
  54. 7.9.5 Qilu Recent Developments
  55. 7.10 Tecnovax
  56. 7.10.1 Tecnovax Company Information
  57. 7.10.2 Tecnovax Business Overview
  58. 7.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Tecnovax Brucellosis Vaccines Product Portfolio
  60. 7.10.5 Tecnovax Recent Developments
  61. 7.11 Hester Biosciences
  62. 7.11.1 Hester Biosciences Company Information
  63. 7.11.2 Hester Biosciences Business Overview
  64. 7.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hester Biosciences Brucellosis Vaccines Product Portfolio
  66. 7.11.5 Hester Biosciences Recent Developments
  67. 7.12 Zoetis
  68. 7.12.1 Zoetis Company Information
  69. 7.12.2 Zoetis Business Overview
  70. 7.12.3 Zoetis Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Zoetis Brucellosis Vaccines Product Portfolio
  72. 7.12.5 Zoetis Recent Developments
  73. 7.13 Onderstepoort Biological
  74. 7.13.1 Onderstepoort Biological Company Information
  75. 7.13.2 Onderstepoort Biological Business Overview
  76. 7.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Onderstepoort Biological Brucellosis Vaccines Product Portfolio
  78. 7.13.5 Onderstepoort Biological Recent Developments
  79. 7.14 Instituto Rosenbusch
  80. 7.14.1 Instituto Rosenbusch Company Information
  81. 7.14.2 Instituto Rosenbusch Business Overview
  82. 7.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Instituto Rosenbusch Brucellosis Vaccines Product Portfolio
  84. 7.14.5 Instituto Rosenbusch Recent Developments
  85. 7.15 Ceva Sante Animale
  86. 7.15.1 Ceva Sante Animale Company Information
  87. 7.15.2 Ceva Sante Animale Business Overview
  88. 7.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Ceva Sante Animale Brucellosis Vaccines Product Portfolio
  90. 7.15.5 Ceva Sante Animale Recent Developments
  91. 7.16 Calier & Biologicos Laverlam
  92. 7.16.1 Calier & Biologicos Laverlam Company Information
  93. 7.16.2 Calier & Biologicos Laverlam Business Overview
  94. 7.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Product Portfolio
  96. 7.16.5 Calier & Biologicos Laverlam Recent Developments
  97. 7.17 Biovet
  98. 7.17.1 Biovet Company Information
  99. 7.17.2 Biovet Business Overview
  100. 7.17.3 Biovet Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Biovet Brucellosis Vaccines Product Portfolio
  102. 7.17.5 Biovet Recent Developments
8 North America
  1. 8.1 North America Brucellosis Vaccines Market Size by Type
  2. 8.1.1 North America Brucellosis Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Brucellosis Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Brucellosis Vaccines Price by Type (2021-2032)
  5. 8.2 North America Brucellosis Vaccines Market Size by Application
  6. 8.2.1 North America Brucellosis Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Brucellosis Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Brucellosis Vaccines Price by Application (2021-2032)
  9. 8.3 North America Brucellosis Vaccines Market Size by Country
  10. 8.3.1 North America Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Brucellosis Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Brucellosis Vaccines Market Size by Type
  2. 9.1.1 Europe Brucellosis Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Brucellosis Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Brucellosis Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Brucellosis Vaccines Market Size by Application
  6. 9.2.1 Europe Brucellosis Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Brucellosis Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Brucellosis Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Brucellosis Vaccines Market Size by Country
  10. 9.3.1 Europe Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Brucellosis Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Brucellosis Vaccines Market Size by Type
  2. 10.1.1 China Brucellosis Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Brucellosis Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Brucellosis Vaccines Price by Type (2021-2032)
  5. 10.2 China Brucellosis Vaccines Market Size by Application
  6. 10.2.1 China Brucellosis Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Brucellosis Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Brucellosis Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Brucellosis Vaccines Market Size by Type
  2. 11.1.1 Asia Brucellosis Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Brucellosis Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Brucellosis Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Brucellosis Vaccines Market Size by Application
  6. 11.2.1 Asia Brucellosis Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Brucellosis Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Brucellosis Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Brucellosis Vaccines Market Size by Country
  10. 11.3.1 Asia Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Brucellosis Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Brucellosis Vaccines Market Size by Type
  2. 12.1.1 SAMEA Brucellosis Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Brucellosis Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Brucellosis Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Brucellosis Vaccines Market Size by Application
  6. 12.2.1 SAMEA Brucellosis Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Brucellosis Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Brucellosis Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Brucellosis Vaccines Market Size by Country
  10. 12.3.1 SAMEA Brucellosis Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Brucellosis Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Brucellosis Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Brucellosis Vaccines Value Chain Analysis
  2. 13.1.1 Brucellosis Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Brucellosis Vaccines Production Mode & Process
  6. 13.2 Brucellosis Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Brucellosis Vaccines Distributors
  9. 13.2.3 Brucellosis Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst